Word

THERAHEMP

Status

Pending

Status Code

641

Status Date

Monday, September 16, 2019

Serial Number

88282891

Mark Type

4000

Filing Date

Wednesday, January 30, 2019

Trademark Owner History

CRYSTAL HEMP S.A. - Original Applicant
LINNEA S.A. - Original Applicant

Classifications

1 Chemicals for use in the pharmaceutical industry; chemical additives for use in the manufacture of pharmaceuticals; botanical extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; botanical extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; plant extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; plant extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; chemicals for use in the cosmetics and food industry; botanical extracts for use in the cosmetics and food industry; botanical extracts for use in the manufacture of cosmetics and dietary supplements; plant extracts, active substances and active chemical ingredients for use in the cosmetics and food industry; plant extracts, active substances and active chemical ingredients for use in the manufacture of cosmetics and dietary supplements

5 Pharmaceuticals based on botanical and plant extracts; pharmaceuticals based on botanical and plant extracts for use in the treatment of skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; dietary supplements based on botanical and plant extracts; dietary supplements based on botanical and plant extracts in the form of pharmaceuticals for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders

Trademark Events

Sep 16, 2019

Notification Of Non-Final Action E-Mailed

Sep 16, 2019

Non-Final Action E-Mailed

Sep 16, 2019

Non-Final Action Written

Sep 9, 2019

Assigned To Examiner

Feb 27, 2019

Assigned To Examiner

Feb 22, 2019

New Application Office Supplied Data Entered In Tram

Feb 2, 2019

New Application Entered In Tram